Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

193,377 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of the efficacy and safety in the treatment strategies between chemotherapy combined with antiangiogenic and with immune checkpoint inhibitors in advanced non-small cell lung cancer patients with negative PD-L1 expression: A network meta-analysis.
Li J, Chen Y, Hu F, Qiang H, Chang Q, Qian J, Shen Y, Cai Y, Chu T. Li J, et al. Front Oncol. 2022 Nov 29;12:1001503. doi: 10.3389/fonc.2022.1001503. eCollection 2022. Front Oncol. 2022. PMID: 36523992 Free PMC article.
Dynamic alterations of ctDNA associate with the therapeutic outcome in the advanced non-small cell lung cancer patients who received sintilimab plus anlotinib regime as 1st line therapy.
Chu T, Yuan J, Lu J, Nie W, Zhong R, Zhang B, Zhang W, Shi C, Qian J, Zhang Y, Zhang X, Teng J, Gao Z, Lou Y, Li J, Qiang H, Zhang C, Li J, Xia X, Zhong H, Han B. Chu T, et al. Among authors: li j. Clin Transl Med. 2023 Jun;13(6):e1277. doi: 10.1002/ctm2.1277. Clin Transl Med. 2023. PMID: 37254636 Free PMC article. No abstract available.
193,377 results
You have reached the last available page of results. Please see the User Guide for more information.